| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc. | Director | Stock Option (right to buy) | 20,000 | 14 Mar 2023 | Direct | ||
| Acer Therapeutics Inc. | Director | Common Stock, $0.0001 par value per share | 0 | 17 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323020443-dunn-john-michael-2023-11-17 | Acer Therapeutics Inc. | 17 Nov 2023 | 1 | $0 | 4 | Director | 20 Nov 2023, 17:07 |
| /report/000120919123019314-dunn-john-michael-2023-03-14 | Acer Therapeutics Inc. | 14 Mar 2023 | 1 | $0 | 4 | Director | 16 Mar 2023, 16:35 |
| /report/000120919122003715-dunn-john-michael-2022-01-14 | Acer Therapeutics Inc. | 14 Jan 2022 | 1 | $0 | 4 | Director | 19 Jan 2022, 15:20 |